Companies: 10,795·Total market cap: $144.5T
Greenrose Acquisition Corp.

Greenrose Acquisition Corp.

GNRSWOTCHealthcare
$0.00
$-0.00(-99.67%)
Market Cap$1768
P/E Ratio
52W High
52W Low
Overview

Greenrose Acquisition Corp. (GNRSW) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · GNRSW · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-3.31gnrsw eps ttm · gnrsw earnings per shareEarnings history
PE Ratio (TTM)gnrsw pe ratio ttm · gnrsw price to earningsPE Ratio deep dive
Revenue (TTM)$50.6Mgnrsw revenue ttm · gnrsw annual revenueFull revenue history
Dividend YieldNo Dividenddoes gnrsw pay dividends · gnrsw dividend yieldDividend history
Shares Outstanding16.1Mgnrsw shares outstanding · gnrsw floatShares outstanding history
Next EarningsTBAgnrsw earnings date · gnrsw next earningsEarnings history

Financial Snapshot

Full Financials
FY 2021Revenue$25.4M▼ 10.50% YoY
201920202021
greenrose acquisition corp. revenue · gnrsw revenue 2021
FY 2021Net Income$17.9M▲ +2408.59% YoY
201920202021
greenrose acquisition corp. net income · gnrsw profit 2021
FY 2021EPS$1.12▼ 67.63% YoY
201920202021
gnrsw eps · greenrose acquisition corp. earnings per share 2021
TTM:Revenue: $50.6MNet Income: -$40.1MEPS: $-3.31View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M-99.00%
YTD-99.00%
1Y-100.00%
5Y-100.00%

About Greenrose Acquisition Corp.

CEONicole Conboy
IPO DateMay 11, 2020
Employees91
CountryUS
Website

Greenrose Acquisition Corp. Greenrose Holding Company Inc., operating via its subsidiaries, specializes in the manufacturing and commercialization of cannabis products. Its core business functions include cultivating, processing…

what is greenrose acquisition corp. · gnrsw stock overview · greenrose acquisition corp. company profile · who is greenrose acquisition corp. ceo · gnrsw OTC · greenrose acquisition corp. headquarters · greenrose acquisition corp. business segments

About Stock Overview & Key Data

Greenrose Acquisition Corp. (GNRSW) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since May 11, 2020. As of the latest trading session, GNRSW stock price is $0.00, with a market capitalization of $1,768. The stock has returned -100.00% over the past 12 months and -99.00% year-to-date.

In fiscal year 2021, Greenrose Acquisition Corp. reported revenue of $25.4M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Greenrose Acquisition Corp. (GNRSW) stock price is $0.00. The stock is traded on OTC under the ticker symbol GNRSW. The 52-week range is $1.00 – $6.00.

GNRSW stock priceGNRSW quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice